Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Movement Disorders : Official Journal of the Movement Disorder Society|November 15, 2025
Safety, Tolerability, Pharmacokinetics, and Brain Target Occupancy of the OGA Inhibitor ASN90 in Healthy ParticipantsRolf Pokorny, J Michael Ryan, Khalid Abd-Elaziz, et al.
Clinical Pharmacology in Drug Development|May 16, 2023
A Phase 1 First-in-Human Single-Ascending-Dose Trial With ESB1609, a Selective Agonist to the Sphingosine-1-Phosphate Receptor 5Nicholas P France, Christopher Rubino, M Courtney Safir, et al.
Cancer Chemotherapy and Pharmacology|August 21, 2024
Relative bioavailability and food effect of the galectin-3 inhibitor selvigaltin (GB1211) administered as a tablet in healthy participants (GALBA-1)Vassilios Aslanis, Khalid Abd-Elaziz, Robert J Slack, et al.
Pageof 2